medigraphic.com
ISSN 2221-2434 (Electronic)

2021, Number 2

<< Back Next >>

Finlay 2021; 11 (2)

Modifiable coronary risk factors and global cardiovascular risk

Sánchez DJA, Sánchez LNE

Language: Spanish
References: 14
Page: 152-159
PDF size: 301.71 Kb.


ABSTRACT

Background: cardiovascular diseases are the most common, serious and risky diseases in terms of mortality and morbidity in much of the world. They are a preventable health problem taken into account the risk factors.
Objective: to characterize the modifiable risk factors epidemiology and global cardiovascular risk.
Method: a descriptive, retrospective, case series study was carried out. The universe included the individuals who attended the cardiology consultation belonging to the César Fornet Fruto University Polyclinic health area of ​​the Banes municipality, Holguín province, during June-December 2020. By simple random sampling, sixty-seven individuals who fulfilled the inclusion/ exclusion criteria were choosen. The studied variables were: age, sex, smoking, obesity, arterial hypertension, diabetes mellitus. A questionnaire designed for the purposes of the study was applied. The Chi Square calculation, Odds Ratio, recurrence risk allowed estimating the association between variables, the magnitude of the association and the recurrence of the event.
Results: the 50-59 and 70-79 age groups represented the 26.9 % each, predominantly female (58.2 %). Hypertension (X2 = 20.7 OR = 54.3 95 % CI [19.14; 154]), diabetes mellitus (X2 = 10 OR = 5.52 95 % CI [2.63, 11.57]) and smoking (X2 = 3.8 OR = 2.8 95 % CI [1.4; 5.68]), determined the occurrence and probability of cardiovascular disease and showed a predominant incidence and risk of occurrence. The coexistence of three or more risk factors affected 29 individuals (43.2 %) and expressed a higher risk (RR = 0.76 IC95 % [0.54, 1.07]). Cardiovascular risk classified as moderate (34.3 %) and low (25.3 %).
Conclusions: cardiovascular risk is determined by multiple modifiable risk factors.


REFERENCES

  1. Royo MA, Armario P, Lobos JM, Botet JP, Villar F, Elosua R, et al. Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev Esp Salud Pública[Internet]. 2016[citado 12 Ene 2021];90(24):[aprox. 10p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272016000100308.

  2. Lacey B, Herrington WG, Preiss D, Lewington S, Armitage J. The role of emerging risk factors in cardiovascular outcomes. Curr Atheroscler Rep. 2017;19(6):28.

  3. Organización Panamerican de la Salud. Enfermedades cardiovasculares[Internet]. New York:OPS;2017[citado 18 Feb 2021]. Disponible en: Disponible en: https://www.paho.org/es/temas/enfermedades-cardiovasculares .

  4. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019[Internet]. La Habana: Dirección Nacional de Estadísticas;2020[citado 15 Ene 2021]. Disponible en: Disponible en: https://bvscuba.sld.cu/anuario-estadistico-de-cuba/ .

  5. Oficina Nacional de Estadística e Información. Anuario Estadístico de Banes 2019[Internet]. La Habana:ONEI;2020[citado 25 Feb 2021]. Disponible en: Disponible en: https://www.onei.gob.cu/sites/default/files/anuario_est_municipal/03_banes_1.pdf .

  6. Ruilope LM, Chagas ACP, Brandão AA, Gómez R, Alcalá JA, Paris JV, et al. Hypertension in Latin America: Current perspectives on trends and characteristics. Hipertens Riesgo Vasc. 2017;34(1):50-6.

  7. Yan L, Xu MT, Yuan L, Chen B, Xu ZR, Guo QH, et al. Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China. J Clin Lipidol. 2016;10(1):150-60.

  8. Karmali KN, Lloyd DM. Implementing Cardiovascular Risk Prediction in Clinical Practice: The Future Is Now. J Am Heart Assoc. 2017;6(4):e006019.

  9. Berdú J, Chacón T, Fonseca A, Pérez RM. Factores de riesgo de las enfermedades cardiovasculares en pacientes de 50 años y menos. Multimed[Internet]. 2020[citado 25 Mar 2021];24(4):[aprox. 8p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-48182020000400772&lng=es&nrm=iso&tlng=es.

  10. Hernández H, Díaz M, Ruiz V, Lanyau Y, Rodríguez L, Llibre J, et al. Valores de riesgo vascular de indicadores metabólicos en adolescentes y ancianos de La Habana. Rev Cubana Salud Pública[Internet]. 2020[citado 21 Abr 2021];46(4):[aprox. 15p.]. Disponible en: https://www.revsaludpublica.sld.cu/index.php/spu/article/view/1827.

  11. Berlier MP, Leguizamón B, Scatularo E, Sigal A, Gamarra AL, Cousirat M, et al. Diferencias de género en los factores de riesgo cardiovascular entre médicos residentes y cardiólogos argentinos Rev CONAREC[Internet]. 2019[citado 12 Abr 2021];34:(149):[aprox. 7p.]. Disponible en: https://www.intramed.net/contenidover.asp?contenidoid=95269.

  12. Pérez JP, Gallego N, Velarde CA, Franco L, Betancur KJ, Valencia AV. Efecto de la hiperglucemia en el síndrome coronario agudo y sus implicaciones en el tratamiento antiagregante plaquetario. Iatreia[Internet]. 2019[citado 20 Feb 2021];32(2):[aprox. 20p.]. Disponible en: https://www.scielo.org.co/pdf/iat/v32n2/0121-0793-iat-32-02-00113.pdf.

  13. Rodríguez BY, Ramírez L, Alvarado T, Cruz M, Peralta JJ. Prevalencia de dislipidemia y riesgo cardiovascular en pacientes con diabetes mellitus tipo 2. Aten Fam[Internet]. 2019[citado 21 Ene 2021];26(3):[aprox. 4p.]. Disponible en: https://dx.doi.org/10.22201/facmed.14058871p.2019.3.70031.

  14. Armas NB, de la Noval GR, Dueñas HA, Castillo JC, Suárez MR, Castillo GA. Estimación del riesgo cardiovascular mediante tablas de la Organización Mundial de la Salud. Área de salud "Héroes del Moncada". Rev Cubana Cardiol Cir Cardiovasc[Internet]. 2014[citado 21 Ene 2021];20(1):[aprox. 10p.]. Disponible en: https://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/357.




2020     |     www.medigraphic.com